Dr. Carlos Bejar M.D.
Carlos Bejar, M.D.

Super Doctors Online 
Identifies top doctors as chosen by their peers and through the independent research of Key Professional Media.

They have chosen Dr. Bejar as one of the Super Doctors in Florida in the practice of Nephrology




Carols
                        Bejar, M.D.

Dr. Bejar completed his medical training and Fellowship at the Cleveland Clinic Ohio and is a former Director of Nephrology at the Cleveland Clinic Florida.  He is Board Certified in both Internal Medicine and Nephrology.

Dr. Bejar’s areas of interest include diabetic nephropathy and kidney disease in autoimmune disorders.  He also completed a special Fellowship in renal stone management and has been honored with the “Top Doc” award for many years.  This year, Dr. Bejar was recognized as a “Best Doctor” by both the New York Times and U. S. News and World Report.  He was also named as a “Top Nephrologist” in Boca Raton.

Dr. Bejar is on the faculty of Nova Southeastern University School of Medicine where he lectures students in Nephrology and also monitors residents as well.

Dr. Bejar is the Vice Chief of Staff at Imperial Point Medical Center, managing this busy department as the hospital undergoes tremendous expansion.  He was previously Chairman of Credentials (for which he was honored for his service) and Vice Chief of Medicine at IPMC.  He continues to lecture nationally, particularly on the topic of Refractory Hypertension and Pharmacology as it pertains to hypertension.

Dr.
                        Carlos Bejar is honored by the North Broward
                        Hospital districtDr. Bejar is recognized by The American Board of Medical Specialties (ABMS), a non-profit organization, which assists 24 approved medical specialty boards in the development and use of standards in the ongoing evaluation and certification of physicians.  ABMS, recognized as the “gold standard” in physician certification, believes higher standards for physicians means better care for patients.

Dr. Bejar is a KOL (Key Opinion Leader) for a pharmaceutical company and is an active lecturer.  He also sits on the Medical Review Board for chronic kidney disease patients in the State of Florida Network 7.